tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Amneal treatment of known or suspected cyanide poisoning granted orphan status
The FlyAmneal treatment of known or suspected cyanide poisoning granted orphan status
2d ago
AMRX
Amneal Pharmaceuticals announces submission of BLA to U.S. FDA for XOLAIR
PremiumThe Fly
Amneal Pharmaceuticals announces submission of BLA to U.S. FDA for XOLAIR
2d ago
AMRX
Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
PremiumRatings
Amneal Pharmaceuticals Positioned for Significant Growth with Strong Product Momentum and Strategic Advantages
4d ago
AMRX
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
PremiumThe Fly
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
5d ago
AMRX
Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorgan
PremiumThe Fly
Amneal Pharmaceuticals price target raised to $14 from $12 at JPMorgan
12d ago
AMRX
Amneal Pharmaceuticals receives FDA approval of sodium oxybate oral solution
PremiumThe FlyAmneal Pharmaceuticals receives FDA approval of sodium oxybate oral solution
17d ago
AMRX
Amneal gets FDA approval for risperidone extended-release injectable suspension
Premium
The Fly
Amneal gets FDA approval for risperidone extended-release injectable suspension
24d ago
AMRX
Amneal Pharma Reports Strong Q2 2025 Results
Premium
Company Announcements
Amneal Pharma Reports Strong Q2 2025 Results
2M ago
AMRX
Amneal Pharma’s Optimistic Q2 Earnings Call Highlights
PremiumCompany Announcements
Amneal Pharma’s Optimistic Q2 Earnings Call Highlights
2M ago
AMRX
Knight Therapeutics announces CREXONT regulatory submission in Mexico
PremiumThe Fly
Knight Therapeutics announces CREXONT regulatory submission in Mexico
2M ago
AMRX
Amneal Pharmaceuticals Reports Strong Q2 2025 Results
PremiumCompany Announcements
Amneal Pharmaceuticals Reports Strong Q2 2025 Results
2M ago
8K
AMRX
Amneal Pharmaceuticals Secures $2.1 Billion in Loans
PremiumCompany Announcements
Amneal Pharmaceuticals Secures $2.1 Billion in Loans
2M ago
8K
AMRX
Amneal Pharmaceuticals Prices $600M Senior Notes Offering
PremiumCompany AnnouncementsAmneal Pharmaceuticals Prices $600M Senior Notes Offering
2M ago
8K
AMRX
Amneal Pharmaceuticals Seeks $1.8 Billion in New Loans
Premium
Company Announcements
Amneal Pharmaceuticals Seeks $1.8 Billion in New Loans
2M ago
8K
AMRX
Amneal Pharmaceuticals Board Restructuring Amidst Financial Growth
Premium
Company Announcements
Amneal Pharmaceuticals Board Restructuring Amidst Financial Growth
2M ago
8K
AMRX
Amneal Pharmaceuticals sees Q2 revenue $720M-$730M, consensus $753.34M
PremiumThe Fly
Amneal Pharmaceuticals sees Q2 revenue $720M-$730M, consensus $753.34M
2M ago
AMRX
Amneal Pharmaceuticals announces proposed refinancing of credit agreement
PremiumThe Fly
Amneal Pharmaceuticals announces proposed refinancing of credit agreement
2M ago
AMRX
Knight Therapeutics announces CREXONT NDS accepted for Health Canada review
PremiumThe Fly
Knight Therapeutics announces CREXONT NDS accepted for Health Canada review
2M ago
AMRX
Amneal Pharmaceuticals announces results from trial evaluating ADL-018
PremiumThe Fly
Amneal Pharmaceuticals announces results from trial evaluating ADL-018
3M ago
AMRX
Amneal Pharmaceuticals receives U.S. FDA approval for prednisolone acetate
PremiumThe FlyAmneal Pharmaceuticals receives U.S. FDA approval for prednisolone acetate
4M ago
AMRX
Amneal Pharmaceuticals initiated with a Buy at Goldman Sachs
Premium
The Fly
Amneal Pharmaceuticals initiated with a Buy at Goldman Sachs
4M ago
AMRX
Amneal Pharmaceuticals recalls Sulfamethoxazole/Trimethoprim tablets, FDA says
Premium
The Fly
Amneal Pharmaceuticals recalls Sulfamethoxazole/Trimethoprim tablets, FDA says
4M ago
AMRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >